Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Friction between the eyelid and the cornea is a mechanical interaction occurring during the blink cycle, specifically involving the lid wiper region of the palpebral conjunctiva (PubMed, PMID: 25211044). In a healthy ocular environment, the tear film acts as a complex lubricant, utilizing mucins and proteins like lubricin (PRG4) to maintain a low coefficient of friction and protect the corneal epithelium from mechanical stress (NIH, PMC3518462). Key molecular components that regulate this friction include membrane-associated mucins (MUC1, MUC4, MUC16) and the proteoglycan lubricin, which provide boundary lubrication and prevent cell-to-cell contact. When lubrication is insufficient, such as in dry eye disease (DED), the resulting increase in friction causes microtrauma, triggering inflammatory pathways and epithelial damage known as lid wiper epitheliopathy (StatPearls, NBK532914). While not a single molecular target, managing this friction is a central therapeutic objective in ophthalmology. Treatments include artificial tears that mimic the rheological properties of natural tears and secretagogues that enhance the biological production of lubricants (PubMed, PMID: 28553064).
Reduction of the friction coefficient between the palpebral conjunctiva and the corneal epithelium by supplementing the tear film or enhancing its stability.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Friction between eyelid and cornea.